Cover Image
Market Research Report
Product code 
1044397

Global Cell Surface Markers Market 2022-2026

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Cell Surface Markers Market 2022-2026
Published: December 6, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the cell surface markers market and it is poised to grow by $ 10.00 bn during 2022-2026, decelerating at a CAGR of 7.40% during the forecast period. Our report on the cell surface markers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the COVID-19 pandemic impact and the introduction of innovative and effective cell surface markers. In addition, the COVID-19 pandemic impact is anticipated to boost the growth of the market as well.

The cell surface markers market analysis includes the application segment and geographic landscape.

Technavio's cell surface markers market is segmented as below:

By Application

  • Disease diagnosis
  • Research and drug discovery

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the higher investment in R&D for launch of effective drugsas one of the prime reasons driving the cell surface markers market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on cell surface markers market covers the following areas:

  • Cell surface markers market sizing
  • Cell surface markers market forecast
  • Cell surface markers market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cell surface markers market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio Rad Laboratories Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann-La Roche Ltd., Grifols SA, QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Also, the cell surface markers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR71681

Table of Contents

  • Executive Summary
    • Market Overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2021
    • Market outlook: Forecast for 2021 - 2026
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Application
    • Market segments
    • Comparison by Application
    • Disease diagnosis - Market size and forecast 2021-2026
    • Research and drug discovery - Market size and forecast 2021-2026
    • Market opportunity by Application
  • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2021-2026
    • Europe - Market size and forecast 2021-2026
    • Asia - Market size and forecast 2021-2026
    • ROW - Market size and forecast 2021-2026
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Landscape disruption
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • Abbott Laboratories
    • Becton Dickinson and Co.
    • Bio Rad Laboratories Inc.
    • Danaher Corp.
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd.
    • Grifols SA
    • QIAGEN NV
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2021 - 2026 ($ billion)
  • 13: Global market: Year-over-year growth 2021 - 2026 (%)
  • 14: Five forces analysis 2021 & 2026
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2021
  • 21: Application - Market share 2021-2026 (%)
  • 22: Comparison by Application
  • 23: Disease diagnosis - Market size and forecast 2021-2026 ($ billion)
  • 24: Disease diagnosis - Year-over-year growth 2021-2026 (%)
  • 25: Research and drug discovery - Market size and forecast 2021-2026 ($ billion)
  • 26: Research and drug discovery - Year-over-year growth 2021-2026 (%)
  • 27: Market opportunity by Application
  • 28: Customer landscape
  • 29: Market share By Geographical Landscape 2021-2026 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2021-2026 ($ billion)
  • 32: North America - Year-over-year growth 2021-2026 (%)
  • 33: Europe - Market size and forecast 2021-2026 ($ billion)
  • 34: Europe - Year-over-year growth 2021-2026 (%)
  • 35: Asia - Market size and forecast 2021-2026 ($ billion)
  • 36: Asia - Year-over-year growth 2021-2026 (%)
  • 37: ROW - Market size and forecast 2021-2026 ($ billion)
  • 38: ROW - Year-over-year growth 2021-2026 (%)
  • 39: Key leading countries
  • 40: Market opportunity By Geographical Landscape ($ billion)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Abbott Laboratories - Overview
  • 48: Abbott Laboratories - Business segments
  • 49: Abbott Laboratories - Key offerings
  • 50: Abbott Laboratories - Key customers
  • 51: Abbott Laboratories - Segment focus
  • 52: Becton Dickinson and Co. - Overview
  • 53: Becton Dickinson and Co. - Business segments
  • 54: Becton Dickinson and Co. - Key offerings
  • 55: Becton Dickinson and Co. - Key customers
  • 56: Becton Dickinson and Co. - Segment focus
  • 57: Bio Rad Laboratories Inc. - Overview
  • 58: Bio Rad Laboratories Inc. - Business segments
  • 59: Bio Rad Laboratories Inc. - Key offerings
  • 60: Bio Rad Laboratories Inc. - Key customers
  • 61: Bio Rad Laboratories Inc. - Segment focus
  • 62: Danaher Corp. - Overview
  • 63: Danaher Corp. - Business segments
  • 64: Danaher Corp. - Key offerings
  • 65: Danaher Corp. - Key customers
  • 66: Danaher Corp. - Segment focus
  • 67: DiaSorin SpA - Overview
  • 68: DiaSorin SpA - Business segments
  • 69: DiaSorin SpA - Key offerings
  • 70: DiaSorin SpA - Key customers
  • 71: DiaSorin SpA - Segment focus
  • 72: F. Hoffmann-La Roche Ltd. - Overview
  • 73: F. Hoffmann-La Roche Ltd. - Business segments
  • 74: F. Hoffmann-La Roche Ltd. - Key offerings
  • 75: F. Hoffmann-La Roche Ltd. - Key customers
  • 76: F. Hoffmann-La Roche Ltd. - Segment focus
  • 77: Grifols SA - Overview
  • 78: Grifols SA - Business segments
  • 79: Grifols SA - Key offerings
  • 80: Grifols SA - Key customers
  • 81: Grifols SA - Segment focus
  • 82: QIAGEN NV - Overview
  • 83: QIAGEN NV - Business segments
  • 84: QIAGEN NV - Key offerings
  • 85: QIAGEN NV - Key customers
  • 86: QIAGEN NV - Segment focus
  • 87: Siemens Healthineers AG - Overview
  • 88: Siemens Healthineers AG - Business segments
  • 89: Siemens Healthineers AG - Key offerings
  • 90: Siemens Healthineers AG - Key customers
  • 91: Siemens Healthineers AG - Segment focus
  • 92: Thermo Fisher Scientific Inc. - Overview
  • 93: Thermo Fisher Scientific Inc. - Business segments
  • 94: Thermo Fisher Scientific Inc. - Key offerings
  • 95: Thermo Fisher Scientific Inc. - Key customers
  • 96: Thermo Fisher Scientific Inc. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations